HK1144390A1 - Compositions for the treatment of neoplastic diseases - Google Patents
Compositions for the treatment of neoplastic diseasesInfo
- Publication number
- HK1144390A1 HK1144390A1 HK10110968.5A HK10110968A HK1144390A1 HK 1144390 A1 HK1144390 A1 HK 1144390A1 HK 10110968 A HK10110968 A HK 10110968A HK 1144390 A1 HK1144390 A1 HK 1144390A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compositions
- treatment
- neoplastic diseases
- neoplastic
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95776407P | 2007-08-24 | 2007-08-24 | |
| GB0716591A GB0716591D0 (en) | 2007-08-24 | 2007-08-24 | Composition |
| PCT/GB2008/002854 WO2009027644A2 (en) | 2007-08-24 | 2008-08-22 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1144390A1 true HK1144390A1 (en) | 2011-02-18 |
Family
ID=39985965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10110968.5A HK1144390A1 (en) | 2007-08-24 | 2010-11-25 | Compositions for the treatment of neoplastic diseases |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110207804A1 (es) |
| EP (1) | EP2190413B1 (es) |
| KR (1) | KR101544498B1 (es) |
| AR (1) | AR073123A1 (es) |
| AU (1) | AU2008291930B2 (es) |
| CA (1) | CA2696622C (es) |
| CL (1) | CL2009001766A1 (es) |
| HK (1) | HK1144390A1 (es) |
| IL (1) | IL204115B (es) |
| MX (1) | MX2010002179A (es) |
| WO (1) | WO2009027644A2 (es) |
| ZA (1) | ZA201001304B (es) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8017395B2 (en) | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
| PL1888123T3 (pl) | 2005-06-08 | 2013-06-28 | Janssen Biotech Inc | Terapia komórkowa chorób degeneracyjnych oka |
| US8741643B2 (en) | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
| US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| EP2185693B1 (en) | 2007-07-31 | 2019-07-03 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| US9089544B2 (en) * | 2007-08-24 | 2015-07-28 | Slotervaart Participaties Bv | Composition |
| EP2229434B1 (en) | 2007-11-27 | 2011-09-07 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
| CA2959401C (en) | 2008-02-21 | 2021-12-07 | Centocor Ortho Biotech Inc. | Methods, surface modified plates and compositions for cell attachment, cultivation and detachment |
| EP2310492B1 (en) | 2008-06-30 | 2015-07-22 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells |
| CA2742268C (en) | 2008-10-31 | 2020-02-18 | Centocor Ortho Biotech Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
| US9012218B2 (en) | 2008-10-31 | 2015-04-21 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| AU2009316583B2 (en) | 2008-11-20 | 2016-04-21 | Janssen Biotech, Inc. | Methods and compositions for cell attachment and cultivation on planar substrates |
| RU2555538C2 (ru) | 2008-11-20 | 2015-07-10 | Сентокор Орто Байотек Инк. | Культура плюрипотентных стволовых клеток на микроносителях |
| BR112012001480A2 (pt) | 2009-07-20 | 2015-09-01 | Janssen Biotech Inc | Diferenciação de células-tronco embriônicas humanas |
| CN102482640B (zh) | 2009-07-20 | 2015-03-11 | 詹森生物科技公司 | 人胚胎干细胞的分化 |
| GB2485113B (en) | 2009-07-20 | 2016-12-28 | Janssen Biotech Inc | Differentiation of human embryonic stem cells into cells of the pancreatic endoderm lineage |
| ES2624644T3 (es) * | 2009-10-01 | 2017-07-17 | Janssen Pharmaceutica, N.V. | Inhibidores de proteasoma para el tratamiento de cáncer |
| RU2664864C1 (ru) | 2009-12-23 | 2018-08-23 | Янссен Байотек, Инк. | Способы увеличения экспрессии ngn3 и nkx6.1 в эндокринных клетках поджелудочной железы |
| US9150833B2 (en) | 2009-12-23 | 2015-10-06 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| WO2011086194A1 (en) * | 2010-01-18 | 2011-07-21 | Cephalon France | Improved oral lysophilisates containing pvp/va |
| WO2011109279A2 (en) | 2010-03-01 | 2011-09-09 | Centocor Ortho Biotech Inc. | Methods for purifying cells derived from pluripotent stem cells |
| CN102884176B (zh) | 2010-05-12 | 2017-09-05 | 詹森生物科技公司 | 人胚胎干细胞的分化 |
| PL2611910T3 (pl) | 2010-08-31 | 2018-06-29 | Janssen Biotech, Inc | Różnicowanie ludzkich embrionalnych komórek macierzystych |
| RU2673946C1 (ru) | 2010-08-31 | 2018-12-03 | Янссен Байотек, Инк. | Дифференцирование плюрипотентных стволовых клеток |
| PL2611909T3 (pl) | 2010-08-31 | 2018-05-30 | Janssen Biotech, Inc | Zróżnicowanie ludzkich embrionalnych komórek macierzystych |
| BR112014015417A8 (pt) | 2011-12-22 | 2017-07-04 | Janssen Biotech Inc | diferenciação de células-tronco embrionárias humanas em células positivas de insulina hormonal únicas |
| AU2013230020B2 (en) | 2012-03-07 | 2018-08-09 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
| CN104334719B (zh) | 2012-06-08 | 2018-02-13 | 詹森生物科技公司 | 人胚胎干细胞向胰腺内分泌细胞的分化 |
| US9352047B2 (en) | 2012-11-14 | 2016-05-31 | Abon Pharmaceuticals, Llc | Oral transmucosal drug delivery system |
| MX2015008578A (es) | 2012-12-31 | 2015-09-07 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9. |
| US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
| RU2018116647A (ru) | 2012-12-31 | 2018-10-24 | Янссен Байотек, Инк. | Культивация эмбриональных стволовых клеток человека в воздушно-жидкостной зоне взаимодействия с целью их дифференцировки в панкреатические эндокринные клетки |
| MX2015008619A (es) | 2012-12-31 | 2016-01-12 | Janssen Biotech Inc | Suspension y agrupamiento de celulas humanas pluripotentes para la diferenciacion a celulas endocrinas pancreaticas. |
| WO2015152433A1 (en) * | 2014-03-31 | 2015-10-08 | Hanmi Pharm. Co., Ltd. | Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same |
| RU2694311C2 (ru) | 2014-05-16 | 2019-07-11 | Янссен Байотек, Инк. | Применение малых молекул для увеличения экспрессии mafa в панкреатических эндокринных клетках |
| MA45479A (fr) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen |
| KR20220002860A (ko) | 2018-12-21 | 2022-01-07 | 모드라 파마슈티컬스 비.브이. | 피크 혈장 수준의 제어에 의한 도세탁셀을 사용하는 암 치료 |
| EP3897611A1 (en) * | 2018-12-21 | 2021-10-27 | Modra Pharmaceuticals B.V. | Combination treatment for solid tumors using docetaxel and a cyp3a inhibitor |
| GB202201935D0 (en) | 2022-02-14 | 2022-03-30 | Modra Pharmaceuticals B V | Methods and compositions for treating cancer in taxane-resistant patients |
| WO2023171894A1 (ko) * | 2022-03-08 | 2023-09-14 | 주식회사 위바이오트리 | 도세탁셀 또는 이의 약학적으로 허용 가능한 염을 포함하는 약학적 조성물 및 이의 제조방법 |
| KR20240003032A (ko) | 2022-06-29 | 2024-01-08 | 주식회사 나노메디팜 | 다중 작용 기전을 가지는 초미립 크기의 항암 약물이 탑재된 나노 약물전달 플랫폼, 이를 포함하는 약제학적 조성물 및 그 제조 방법 |
| EP4385507A1 (en) | 2022-12-13 | 2024-06-19 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Combination treatment for solid tumors using cabazitaxel and a cyp3a inhibitor |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2371836C (en) | 1999-05-27 | 2006-01-31 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
| US6610317B2 (en) * | 1999-05-27 | 2003-08-26 | Acusphere, Inc. | Porous paclitaxel matrices and methods of manufacture thereof |
| US20080305173A1 (en) * | 2001-07-31 | 2008-12-11 | Beuford Arlie Bogue | Amorphous drug beads |
| US8071133B2 (en) * | 2001-08-20 | 2011-12-06 | Stiefel Laboratories, Inc. | Oral dosage forms of water insoluble drugs and methods of making the same |
| HUP0500843A2 (hu) * | 2001-12-20 | 2005-12-28 | Bristol-Myers Squibb Co., | Fokozott biológiai hasznosulású, szájon át hatásos taxánszármazékokat tartalmazó gyógyszerkészítmények |
| AU2003256157A1 (en) * | 2002-08-05 | 2004-02-23 | Dsm Ip Assets B.V. | Oral dosage forms of water insoluble drugs and methods of making the same |
| KR100508518B1 (ko) * | 2002-11-13 | 2005-08-17 | 한미약품 주식회사 | 초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체 |
| WO2006026592A2 (en) * | 2004-08-27 | 2006-03-09 | Spherics, Inc. | Oral administration of poorly absorbed drugs, methods and compositions related thereto |
| KR20080003322A (ko) * | 2005-02-24 | 2008-01-07 | 엘란 파마 인터내셔널 리미티드 | 도세탁셀 및 이의 유사체의 나노입자 배합물 |
| EP2139470A4 (en) * | 2007-03-23 | 2010-07-28 | Elan Pharma Int Ltd | GAMMA RADIATION STERILIZED NANOPARTICULAR DOCETAXEL COMPOSITIONS AND METHODS OF MAKING SAME |
-
2008
- 2008-08-22 WO PCT/GB2008/002854 patent/WO2009027644A2/en active Application Filing
- 2008-08-22 EP EP08788414.4A patent/EP2190413B1/en active Active
- 2008-08-22 KR KR1020107004111A patent/KR101544498B1/ko active IP Right Grant
- 2008-08-22 CA CA2696622A patent/CA2696622C/en active Active
- 2008-08-22 AU AU2008291930A patent/AU2008291930B2/en active Active
- 2008-08-22 MX MX2010002179A patent/MX2010002179A/es active IP Right Grant
-
2009
- 2009-08-24 CL CL2009001766A patent/CL2009001766A1/es unknown
- 2009-08-24 US US13/060,037 patent/US20110207804A1/en not_active Abandoned
- 2009-08-24 AR ARP090103252A patent/AR073123A1/es unknown
-
2010
- 2010-02-23 ZA ZA2010/01304A patent/ZA201001304B/en unknown
- 2010-02-23 IL IL204115A patent/IL204115B/en active IP Right Grant
- 2010-11-25 HK HK10110968.5A patent/HK1144390A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2190413A2 (en) | 2010-06-02 |
| MX2010002179A (es) | 2010-04-27 |
| AU2008291930A1 (en) | 2009-03-05 |
| AU2008291930B2 (en) | 2014-04-17 |
| ZA201001304B (en) | 2013-08-28 |
| WO2009027644A3 (en) | 2009-12-17 |
| EP2190413B1 (en) | 2015-01-28 |
| CA2696622A1 (en) | 2009-03-05 |
| KR20100044237A (ko) | 2010-04-29 |
| CL2009001766A1 (es) | 2010-07-09 |
| IL204115B (en) | 2019-05-30 |
| CA2696622C (en) | 2016-07-19 |
| US20110207804A1 (en) | 2011-08-25 |
| AR073123A1 (es) | 2010-10-13 |
| WO2009027644A2 (en) | 2009-03-05 |
| WO2009027644A8 (en) | 2009-04-30 |
| KR101544498B1 (ko) | 2015-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1144390A1 (en) | Compositions for the treatment of neoplastic diseases | |
| HK1256861A1 (zh) | 用於治療胃腸道炎症的組合物 | |
| IL186749A0 (en) | Dihydrothienopyrimidines for the treatment of inflammatory diseases | |
| IL200862A0 (en) | 3-imidazolyl-indoles for the treatment of proliferative diseases | |
| EP2125855A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASES | |
| HK1131141A1 (en) | Imidazolothiazole compounds for the treatment of disease | |
| PL2056842T3 (pl) | Modyfikowany galaktozyloceramid do leczenia chorób nowotworowych | |
| EP2217238A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO PROTEINURIA | |
| IL205137A0 (en) | 5-cyanothienopyridines for the treatment of tumours | |
| IL209360A (en) | Medications containing pm00104 for the treatment of multiple myeloma | |
| IL212057A0 (en) | Compositions for the treatment of bowel diseases with granulated mesalamine | |
| PL2022504T3 (pl) | Maść do leczenia hemoroidów | |
| GB0909297D0 (en) | Composition for the treatment of skin conditions | |
| EP2150270A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CANCER | |
| GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea | |
| IL210066A0 (en) | Novel ortho-aminoanilides for the treatment of cancer | |
| PL2307380T3 (pl) | Pochodne N’-nitroksyalkilonikotynamidu do leczenia chorób układu sercowo-naczyniowego | |
| PL2252302T3 (pl) | Kompozycja do leczenia zapalenia kości i stawów | |
| IL184620A0 (en) | Composition for the treatment of inflammation | |
| GB0602857D0 (en) | The treatment of sialorrhoea | |
| GB0715255D0 (en) | Thiadiazol-piperazinyl derivatives for the treatment of neurodegenerative diseases | |
| GB0715257D0 (en) | Phenylthiazolylpiperazine derivatives for the treatment of nuero degenerative diseases | |
| GB0700755D0 (en) | The Treatment of ophthalmic diseases | |
| GB0604114D0 (en) | Combinations for the treatment of cancer | |
| IL202502A (en) | Cxcl11 for the treatment of inflammatory diseases |